Royal Bank of Canada’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.79M | Buy |
102,791
+84,244
| +454% | +$1.47M | ﹤0.01% | 3110 |
|
|
2025
Q1 | $234K | Buy |
18,547
+16,969
| +1,075% | +$214K | ﹤0.01% | 4244 |
|
|
2024
Q4 | $17K | Sell |
1,578
-3,964
| -72% | -$42.7K | ﹤0.01% | 5687 |
|
|
2024
Q3 | $80K | Buy |
5,542
+713
| +15% | +$10.3K | ﹤0.01% | 5025 |
|
|
2024
Q2 | $41K | Buy |
4,829
+2,640
| +121% | +$22.4K | ﹤0.01% | 5357 |
|
|
2024
Q1 | $23K | Sell |
2,189
-5,815
| -73% | -$61.1K | ﹤0.01% | 5419 |
|
|
2023
Q4 | $44K | Buy |
8,004
+4,162
| +108% | +$22.9K | ﹤0.01% | 5519 |
|
|
2023
Q3 | $15K | Buy |
3,842
+248
| +7% | +$968 | ﹤0.01% | 5789 |
|
|
2023
Q2 | $24K | Buy |
3,594
+3,589
| +71,780% | +$24K | ﹤0.01% | 5669 |
|
|
2023
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 6916 |
|
|
2022
Q4 | $0 | Buy |
+5
| New | – | ﹤0.01% | 7127 |
|
|
2022
Q2 | – | Sell |
-1,260
| Closed | -$4K | – | 7121 |
|
|
2022
Q1 | $4K | Sell |
1,260
-2,861
| -69% | -$9.08K | ﹤0.01% | 6848 |
|
|
2021
Q4 | $28K | Buy |
4,121
+1,781
| +76% | +$12.1K | ﹤0.01% | 6116 |
|
|
2021
Q3 | $23K | Buy |
2,340
+1,347
| +136% | +$13.2K | ﹤0.01% | 6113 |
|
|
2021
Q2 | $31K | Sell |
993
-165
| -14% | -$5.15K | ﹤0.01% | 5826 |
|
|
2021
Q1 | $51K | Buy |
+1,158
| New | +$51K | ﹤0.01% | 5375 |
|